NationalStockNumber.INFO
Worldwide distributor of NSN parts and consumables located in the USA.
Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Anticonvulsants, hypnotics and sedatives, in measured doses or in forms or packaging for retail sale
Medicaments containing alkaloids and their derivatives, n.E.S., in dosage form or retail packings
Pharmaceutical preparations
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
058770 - Drugs/medicines/vitamins noi
532 - Drugs and medicines excluding pencillin, sulfa, serums, vaccines, and vitamins (not requiring temperature control)
6 - Highest sensitivity, category i, aa&e, classified secret
A - Shipment is not a consolidation and does not exceed 84 inches in any dimension.
M - Medical supplies, equipment, samples, records, etc.
W - Rating variable
Z - No special type of cargo code applicable
Questions & Answers: |
|
| What are the historical prices recorded for this stock number? | |
| Historical data shows pricing from $10.77 to $17.96.. | |
| Does NSN 6505-00-117-8749 have a shelf life? | |
| No. There is no shelf life applicable for this NSN. | |
| What NATO entities are users of this NSN? | |
| Health Services Administration, and Kuwait | |
| What is the NIIN of NSN 6505-00-117-8749? | |
| 001178749 or 00-117-8749 | |
| Does NSN 6505-00-117-8749 require demilitarization? | |
| Yes - ITAR Controlled | |
| What is the most recent solicitation for NSN 6505-00-117-8749? | |
| No solicitations for this NSN. | |
| When was this national stock number assigned to the federal catalog? | |
| Mar 16, 1973 | |
Ld50 lc50 mixture: tlv: none established
routes of entry: inhalation: yes skin: no ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: industrial exposure: skin contact:
possible rash. Ingestion or inhalation: it is advisible to
anticipate that signs of cns depression associated with its oral
clinical administration might manifest in the evnt of industrial
overexposure.
explanation of carcinogenicity: not carcinogenic.
effects of overexposure: these signs include dizziness, drowsiness,
lightheadedness, tendency to fall, irritability, apprehension,
weakness, generslized pain, headache, possible flushing,
perspiring, hypersalivation, loss of appetite, mood changes,
visual effects,hallucinations.
medical cond aggravated by exposure: none specified by manufacturer.
First aid: eye contact-irrigate sutfaces with water for 15 minutes. Skin
contact-flush area with soap & water for 15 minutes. Ingestion-call
physician immediately. Supportive measures should be employed
includin g immediate gastric lavage. Intravenousfluids should be
administered and an adequate airway maintained.
Hcc: n1
melt/freeze pt: m.P/f.P text: 208-218c
solubility in water: soluble
appearance and odor: off-white to yellow crystalline powder; slight odor
or odorless.
Stability indicator/materials to avoid: yes
acids and bases in solution (cause hydrolysis to benzophenone).
stability condition to avoid: light; ph>7 or
hazardous decomposition products: none specified by manufacturer.
Waste disposal methods: destroy substance and its formulations in a
manner approved for scheduled iv controlled substances. Dispose of
destructed waste in a federal or state licensed secured chemical
landfill.
Ingred name: non hazardous ingredient
other rec limits: none recommended